Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $5 Price Target
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results
Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study
Albemarle Is Out of Wells Fargo's Signature Picks
Pfizer/ Sangamo Gene Therapy for Hemophilia A Succeeds in Late-stage Trial
I Am 102927471 :![](https://emoticon.futunn.com/moomoo_winter_day/mw_19.png)